Debrecen, 2002 - Debreceni Egyetem Orvos- és ...

18. Péter, M.J., Varga, Z., Hajdú, P., Gáspár, R. Jr., Damjanovich, S., Horjales, E., Possani,
L.D., and Panyi, G.: Effects of toxins Pi2 and Pi3 on human T lymphocyte Kv1.3 channels: the role
of Glu7 and Lys24.
J. Membr. Biol. 179, 13-25, 2001.
19. Szöllõsi, J., Sebestyén, Z., and Nagy, P.: Molecular superstructures in biological membranes.
In: Molecular and Cellular Biology: from Plant to Human, Krasznai, Z, Mátyus, L., and Van Duijn, B.,
Eds. Foundation for Single Cell Research, Leiden, 2000. pp. 184-195.
20. Varga, Z., Panyi, G., Péter, M.J., Pieri, C., Csécsei, G., Damjanovich, S., and Gáspár, R. Jr.:
Multiple binding sites for melatonin on Kv1.3.
Biophys. J. 80, 1280-1297, 2001.
Department of Clinical Biochemistry and Molecular Pathology
1. Antal-Szalmas, P.: Evaluation of CD14 in host defense.
Eur. J. Clin. Invest. 30, 167-179, 2000.
2. Antal-Szalmas, P., Poppelier, M.J.J.G., Broekhuisen, R., Verhoef, J., van Kessel, K.P.M., van
Strijp, J.A.G.: Diverging pathways for lipopolysaccharide (LPS) and CD14 in human monocytes.
Cytometry 41, 279-288, 2000.
3. Balogh, I., Szõke, G., Kárpáti, L., Wartiovaara, U., Katona, É., Komáromi, I., Haramura, G.,
Pfliegler, Gy., Mikkola, H., Muszbek, L.: Val34Leu polymorphism of plasma factor XIII: biochemistry
and epidemiology in familial thrombophilia.
Blood 96, 2479-86, 2000.
4. Bonnefoy, A., Harsfalvi, J., Pfliegler, G., Fauvel-Lafeve, F., Legrand, C.: The subendothelium of
the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and
collagen types I, III and VI.
Thromb. Haemost. 85, 552-9, 2001.
5. Góth, L.: A new type of inherited catalase deficiencies: Its characterization and comparison to the
Japanese and Swiss type of acatalasemia.
Blood Cells Mol. Dis. 27, 512-7, 2001.
6. Góth, L., Eaton, J.W.: Hereditary catalase deficiences and increased risk of diabetes.
Lancet 356, 1820-1, 2000,
7. Góth, L., Rass, P., Madarasi, I.: A novel catalase mutation detected by PCR-SSCP, nucleotide
sequencing and Western blot analyzes is responsible for the type C of Hungarian acatalasemia.
Electrophoresis 22, 49-51, 2001.
8. Karászi, É., Jakab, K., Homolya, L., Szakács, G., Holló, Zs., Telek, B., Kiss, A., Rejtõ, L.,
Nahajevszky, S., Sarkadi, B., Kappelmayer, J.: Calcein assay for multidrug resistance reliably
predicts therapy response and survival rate in acute myeloid leukaemia.
Brit. J. Haematol. 112, 308-314, 2001.
9. Kárpáti, L., Penke, B., Katona, É., Balogh, I., Vámosi, Gy., Muszbek, L.: A modified,
optimized kinetic photometric assay for he determination of blood coagulation factor XIII activity in
plasma.
Clin. Chem. 46, 1946-55, 2000.
10. Muszbek, L.: Deficiency causing mutations and common polymorphisms in the Factor XIII-A
gene.
Thromb. Haemost. 84, 524-7, 2000.
11. Regeczy, N., Balogh, I., Lakos, G.: Risk for venous thrombosis in autoimmune diseases with
antiphospholipid antibodies and factor V Leiden mutation among Hungarian patients.
J. Rheumatol. 27, 2723-5, 2000.